ERBB2 and neoplasm: The increased frequency of a myeloid-rich stroma may be due to HER2xHER2 and EGFRxHER2 T-BsAbs effectively driving the elimination of EGFR+HER2+ tumor cells while sparing EGFR−HER2− stromal cells.